FRED ALGER MANAGEMENT, LLC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 194 filers reported holding GW PHARMACEUTICALS PLC in Q1 2018. The put-call ratio across all filers is 1.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
FRED ALGER MANAGEMENT, LLC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q4 2020$5,000
-85.7%
47
-87.1%
0.00%
Q3 2020$35,000
-100.0%
364
-99.9%
0.00%
-100.0%
Q2 2020$89,185,000
-32.8%
726,735
-52.1%
0.29%
+0.7%
Q1 2020$132,808,000
+65.7%
1,516,594
+97.8%
0.29%
-1.0%
Q4 2019$80,163,000
+9.7%
766,671
+20.7%
0.30%
+2.8%
Q3 2019$73,045,000
-15.3%
635,004
+26.9%
0.29%
-13.3%
Q2 2019$86,284,000
+23.8%
500,519
+21.1%
0.33%
+19.1%
Q1 2019$69,679,000
+2.7%
413,356
-40.7%
0.28%
-10.9%
Q4 2018$67,841,000
+5.7%
696,594
+87.5%
0.31%
+29.5%
Q3 2018$64,174,000
+43.0%
371,509
+15.5%
0.24%
+28.2%
Q2 2018$44,888,000
+321.9%
321,688
+240.7%
0.19%
+283.7%
Q1 2018$10,639,000
+86.3%
94,424
+118.3%
0.05%
+88.5%
Q4 2017$5,710,000
+149.8%
43,256
+92.1%
0.03%
+136.4%
Q3 2017$2,286,000
+356.3%
22,521
+350.4%
0.01%
+450.0%
Q2 2017$501,000
-17.2%
5,0000.0%0.00%
-33.3%
Q1 2017$605,000
+20.3%
5,000
+11.1%
0.00%0.0%
Q4 2016$503,000
+8.2%
4,500
+28.6%
0.00%
+50.0%
Q3 2016$465,000
+125.7%
3,500
+55.6%
0.00%
+100.0%
Q2 2016$206,000
-74.2%
2,250
-80.4%
0.00%
-75.0%
Q4 2015$799,000
+21.4%
11,500
+59.7%
0.00%0.0%
Q3 2015$658,0007,2000.00%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q1 2018
NameSharesValueWeighting ↓
VHCP Management, LLC 311,853$25,213,00011.33%
Iguana Healthcare Management, LLC 50,000$4,043,0002.16%
Ghost Tree Capital, LLC 35,000$2,830,0001.54%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 354,278$28,643,0001.06%
Cupps Capital Management, LLC 100,213$8,102,0000.75%
CLOUGH CAPITAL PARTNERS L P 192,600$15,572,0000.58%
FARALLON CAPITAL MANAGEMENT LLC 244,000$19,727,0000.32%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 105,200$8,505,0000.31%
Eventide Asset Management 25,000$2,021,0000.28%
PRUDENTIAL PLC 836,124$67,601,0000.28%
View complete list of GW PHARMACEUTICALS PLC shareholders